Last reviewed · How we verify
Oraflex (BENOXAPROFEN)
At a glance
| Generic name | BENOXAPROFEN |
|---|---|
| Drug class | benoxaprofen |
| Target | Arachidonate 5-lipoxygenase |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
- Rheumatoid arthritis
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oraflex CI brief — competitive landscape report
- Oraflex updates RSS · CI watch RSS